Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akira Yokoi

Showing results (21-30 of 132) with videos related to

Pageof 14
Sort By:
Cancer Science|October 7, 2021
Extracellular microRNA profiling for prognostic prediction in patients with high-grade serous ovarian carcinomaKosuke Yoshida, Akira Yokoi, Juntaro Matsuzaki, et al.
BBA Advances|February 6, 2025
Extracellular vesicles display distinct glycosignatures in high-grade serous ovarian carcinomaKristina Mae Bienes, Akira Yokoi, Masami Kitagawa, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|June 25, 2019
Short- and Long-Term Outcomes of Extremely Preterm Infants in Japan According to Outborn/Inborn Birth StatusYoshihito Sasaki, Kaoru Ishikawa, Akira Yokoi, et al.
Analytical Chemistry|April 9, 2009
Quantitative phosphorus metabolomics using nanoflow liquid chromatography-tandem mass spectrometry and culture-derived comprehensive global internal standardsTaisuke Uehara, Akira Yokoi, Ken Aoshima, et al.
Proteomics|October 3, 2025
Differential Proteomics of Large Extracellular Vesicles in Ovarian CancerKazuhiro Suzuki, Yusuke Yamamoto, Masami Kitagawa, et al.
Biochemical and Biophysical Research Communications|November 16, 2025
Genomic insights and therapeutic efficacy of PARP inhibitors in a high-LOH patient-derived xenograft from malignant transformation of ovarian teratomaAtsushi Nakagawa, Satoshi Tamauchi, Wang Xinyuan, et al.
Cancer Letters|March 14, 2019
Drug library screen reveals benzimidazole derivatives as selective cytotoxic agents for KRAS-mutant lung cancerIwao Shimomura, Akira Yokoi, Isaku Kohama, et al.
BMC Cancer|January 26, 2026
Risk factors for recurrent cases of early-stage uterine sarcoma after complete surgical resectionYukari Nagao, Akira Yokoi, Kosuke Yoshida, et al.
Cancers|February 4, 2021
Extracellular miRNAs as Predictive Biomarkers for Glypican-3-Derived Peptide Vaccine Therapy Response in Ovarian Clear Cell CarcinomaMayu Ukai, Akira Yokoi, Kosuke Yoshida, et al.
Scientific Reports|January 3, 2025
Chemotherapeutic hormesis induced by the tumor microenvironment in refractory ovarian cancerXuboya Chang, Satoshi Tamauchi, Atsushi Nakagawa, et al.
Pageof 14

Showing results (21-30 of 132) with videos related to

Sort By:
Pageof 14
Cancer Science|October 7, 2021
Extracellular microRNA profiling for prognostic prediction in patients with high-grade serous ovarian carcinomaKosuke Yoshida, Akira Yokoi, Juntaro Matsuzaki, et al.
BBA Advances|February 6, 2025
Extracellular vesicles display distinct glycosignatures in high-grade serous ovarian carcinomaKristina Mae Bienes, Akira Yokoi, Masami Kitagawa, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|June 25, 2019
Short- and Long-Term Outcomes of Extremely Preterm Infants in Japan According to Outborn/Inborn Birth StatusYoshihito Sasaki, Kaoru Ishikawa, Akira Yokoi, et al.
Analytical Chemistry|April 9, 2009
Quantitative phosphorus metabolomics using nanoflow liquid chromatography-tandem mass spectrometry and culture-derived comprehensive global internal standardsTaisuke Uehara, Akira Yokoi, Ken Aoshima, et al.
Proteomics|October 3, 2025
Differential Proteomics of Large Extracellular Vesicles in Ovarian CancerKazuhiro Suzuki, Yusuke Yamamoto, Masami Kitagawa, et al.
Biochemical and Biophysical Research Communications|November 16, 2025
Genomic insights and therapeutic efficacy of PARP inhibitors in a high-LOH patient-derived xenograft from malignant transformation of ovarian teratomaAtsushi Nakagawa, Satoshi Tamauchi, Wang Xinyuan, et al.
Cancer Letters|March 14, 2019
Drug library screen reveals benzimidazole derivatives as selective cytotoxic agents for KRAS-mutant lung cancerIwao Shimomura, Akira Yokoi, Isaku Kohama, et al.
BMC Cancer|January 26, 2026
Risk factors for recurrent cases of early-stage uterine sarcoma after complete surgical resectionYukari Nagao, Akira Yokoi, Kosuke Yoshida, et al.
Cancers|February 4, 2021
Extracellular miRNAs as Predictive Biomarkers for Glypican-3-Derived Peptide Vaccine Therapy Response in Ovarian Clear Cell CarcinomaMayu Ukai, Akira Yokoi, Kosuke Yoshida, et al.
Scientific Reports|January 3, 2025
Chemotherapeutic hormesis induced by the tumor microenvironment in refractory ovarian cancerXuboya Chang, Satoshi Tamauchi, Atsushi Nakagawa, et al.
Pageof 14